STRATA CRITICAL MEDICAL, INC. (SRTA) Net margin 2019–2025
STRATA CRITICAL MEDICAL, INC. (SRTA) net profit margin by fiscal year — reported net income divided by reported revenue.
21.0%FY2025 · since FY2019: 7.5% → 21.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 21.0% | +39.6 pp |
| FY2024 | -18.6% | +6.3 pp |
| FY2023 | -24.9% | -6.2 pp |
| FY2022 | -18.7% | +60.6 pp |
| FY2021 | -79.3% | +8.3 pp |
| FY2020 | -87.6% | -95.0 pp |
| FY2019 | 7.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SRTA financial trends
SRTA RevenueSRTA Net incomeSRTA Gross profitSRTA Gross marginSRTA Operating incomeSRTA Operating marginSRTA Operating cash flowSRTA Free cash flowSRTA Capital expendituresSRTA Return on equitySRTA Stock buybacksSRTA Dividends paidSRTA Total assetsSRTA Total liabilitiesSRTA Shareholders’ equitySRTA overview →